EQUELS THOMAS K (Exec. Vice Chairman/CEO/Pres.) purchased 2.2% of their position (41K shares) of AIM IMMUNOTECH INC. on the open market
Open‑market purchase worth $2.6K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/7/2025ACC: 0001641172-25-002977
DirectorOfficer· Exec. Vice Chairman/CEO/Pres.
Since Jul 2018
+41K
Net shares
Net buyer
$2.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
41K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+41K
Price / share
$0.06
Trade value
$2.58K
% of position
2.2%
4/4/2025
1.86M→1.90M
Total
Net shares
+41K
Net value
$2.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/4/2025 | P · Purchase | +41K | $0.06 | $2.58K | 2.2% | 1.86M | 1.90M |
| Total | +41K | $2.58K | ||||||
Derivative Transactions0
No derivative transactions reported